C-reactive protein is neither a marker nor a mediator of atherosclerosis
Author:
- 4 March 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Nephrology
- Vol. 4 (5) , 234-235
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE−/− miceAtherosclerosis, 2008
- Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemiaProceedings of the National Academy of Sciences, 2007
- C-reactive protein and cardiovascular disease: Weighing the evidenceCurrent Atherosclerosis Reports, 2006
- Targeting C-reactive protein for the treatment of cardiovascular diseaseNature, 2006
- Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein ItselfCirculation Research, 2005
- C-Reactive Protein–Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and LipopolysaccharideArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient miceProceedings of the National Academy of Sciences, 2005
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994
- Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.Journal of Experimental Medicine, 1982